Fundz

Pinteon Therapeutics Announces $3 Million Award From Advanced Technology International To Support Phase 1 Study Of Pnt001 In Patients With Acute Traumatic Brain Injury

PRIVATEJun 17, 2021

Round Type

Grant

Newton CentreInformation TechnologyBiotechnology

Description

Pinteon Therapeutics, a biotechnology company focused on protecting neuronal health by targeting neurotoxic forms of tau, today announced it has received a $3 million award from Advanced Technology International (ATI) to support the company’s Phase 1 study of PNT001 in hospitalized patients with acute traumatic brain injury. ATI is a nonprofit contractor of the U.S. Department of Defense (DOD) that identifies and sources solutions for the DOD from industry and academia. The funds will be awarded as milestone payments as the trial progresses.

Quick answer

Pinteon Therapeutics, Inc. raised an undisclosed amount in a Grant round, dated June 17, 2021. Pinteon Therapeutics, Inc. is based in Newton Centre, Massachusetts, United States.

How much did Pinteon Therapeutics, Inc. raise?
Pinteon Therapeutics, Inc. raised an undisclosed amount in a Grant round on June 17, 2021.
What does Pinteon Therapeutics, Inc. do?
Pinteon Therapeutics is advancing clinical studies of a novel antibody that aims to interrupt the spread of toxic tau and protect and preserve brain function in patients with neurodegenerative disease.
Where is Pinteon Therapeutics, Inc. based and how big is it?
Pinteon Therapeutics, Inc. is based in Newton Centre, Massachusetts, United States.
Who are the decision-makers at Pinteon Therapeutics, Inc?
Fundz holds 1 contact at Pinteon Therapeutics, Inc., including the Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Pinteon Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Artio Medical, Inc. raised an undisclosed amount on July 30, 2021.
  • Cerium Pharmaceuticals, Inc. raised $8.9M on July 30, 2021.
  • Neuralink raised $200M (Funding Round) on July 30, 2021.
  • SkinJect, Inc. raised $895K (Seed) on July 30, 2021.
  • Neuralink raised $205M (Funding Round) on July 30, 2021.
  • Astek Diagnostics raised $345K (Seed) on July 30, 2021.

Who to call at Pinteon Therapeutics, Inc., and when

A new round usually means Pinteon Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Pinteon Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Pinteon Therapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Pinteon Therapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Pinteon Therapeutics, Inc.

Location

1188 CENTRE STREET

Newton Centre, Massachusetts, United States

About

Pinteon Therapeutics is advancing clinical studies of a novel antibody that aims to interrupt the spread of toxic tau and protect and preserve brain function in patients with neurodegenerative disease. Pinteon’s lead asset, PNT001, is the only antibody in development that targets cis-pT231 tau, a neurotoxic epitope which has been identified in multiple preclinical studies as a potent driver of neurodegenerative disease. Pinteon is led by an experienced management team with strong track records in CNS drug discovery and development and is funded by Morningside Ventures. For more information, visit pinteon.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Pinteon Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsLarry A., Director hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Pinteon Therapeutics, Inc.'s next move

See what Strategic adds

Pinteon Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.